Cardinal Health Inc. (CAH) Q3 2020 earnings call dated May 11, 2020 Corporate Participants: Kevin Moran -- Vice President, Investor Relations Mike Kaufmann -- Chief Executive
Categories
Health Care
Mylan (MYL) swings to a profit in Q1, reaffirms FY20 outlook
Mylan N.V. (NASDAQ: MYL) reported its financial results for the quarter ended March 31, 2020, on Monday before the market opens. The
A visual representation of Cardinal Health’s (CAH) Q3 2020 earnings results
Cardinal Health (NYSE: CAH) reported third quarter 2020 earnings results today. Revenues amounted to $39.2 billion, up 11% year-over-year. GAAP EPS increased
HMS Holdings Corp (NASDAQ: HMSY) Q1 2020 Earnings Call Transcript
HMS Holdings Corp (HMSY) Q1 2020 earnings call dated May 08, 2020 Corporate Participants: Robert P. Borchert -- Senior Vice President Investor Relations Bill
Amyris Inc. (NASDAQ: AMRS) Q1 2020 Earnings Call Transcript
Amyris Inc. (AMRS) Q1 2020 earnings call dated May 08, 2020 Corporate Participants: Peter DeNardo -- Director, Investor Relations and Corporate Communications John Melo -- Director,
AmerisourceBergen Corp (NYSE: ABC) Q2 2020 Earnings Call Transcript
AmerisourceBergen Corp (ABC) Q2 2020 earnings call dated May. 07, 2020 Corporate Participants: Bennett S. Murphy -- Senior Vice President, Investor Relations Steven H.
Becton Dickinson & Co. (NYSE: BDX) Q2 2020 Earnings Call Transcript
Becton Dickinson & Co. (BDX) Q2 2020 earnings call dated May 08, 2020 Corporate Participants: Monique N. Dolecki -- Investor Relations Tom Polen -- Chief Executive
Dentsply Sirona (XRAY) slips to a loss in Q1 but beats estimates
Dentsply Sirona Inc. (NASDAQ: XRAY) reported its preliminary financial results for the quarter ended March 31, 2020, on Friday before the bell.
Danaher Corp (NYSE: DHR) Q1 2020 Earnings Call Transcript
Danaher Corp (DHR) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Matthew E. Gugino -- Vice President of Investor Relations Thomas P.
BioTelemetry Inc (NASDAQ: BEAT) Q1 2020 Earnings Call Transcript
BioTelemetry Inc (BEAT) Q1 2020 earnings call dated May. 06, 2020 Corporate Participants: Joseph H. Capper -- President and Chief Executive Officer Heather Getz -- Executive
Bristol-Myers Squibb Co (NYSE: BMY) Q1 2020 Earnings Call Transcript
Bristol-Myers Squibb Co (BMY) Q1 2020 earnings call dated May. 07, 2020 Corporate Participants: Timothy Power -- Vice President, Investor Relations Giovanni Caforio -- Chairman of
Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) Q1 2020 Earnings Call Transcript
Alnylam Pharmaceuticals Inc (ALNY) Q1 2020 earnings call dated May. 06, 2020 Corporate Participants: Christine Regan Lindenboom -- Vice President, Investor Relations and Corporate
Infographic: Highlights of Bausch Health (BHC) Q1 2020 earnings results
Bausch Health Companies Inc. (NYSE: BHC) reported a wider loss in the first quarter of 2020 due to lower income taxes benefit
Horizon Therapeutics PLC (NASDAQ: HZNP) Q1 2020 Earnings Call Transcript
Horizon Therapeutics PLC (HZNP) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Tina Ventura -- Senior Vice President, Investor Relations Tim Walbert -- Chairman,
Visual Representation of Bristol-Myers Squibb Company (BMY) Q1 2020 earnings
Bristol-Myers Squibb Company (NYSE: BMY) reported first-quarter 2020 financial results before the regular trading hours on Thursday. The results were better than
Infographic: Teva Pharmaceuticals (TEVA) Q1 2020 earnings results
Teva Pharmaceuticals' (NYSE: TEVA) first quarter 2020 results beat consensus estimates. The drugmaker reported adjusted earnings of $0.76 per share on revenue
Tivity Health, Inc. (NASDAQ: TVTY) Q1 2020 Earnings Call Transcript
Tivity Health, Inc. (TVTY) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Bob Greczyn -- Interim Chief Executive Officer Steve Janicak -- President of
CVS Health (NYSE: CVS) Q1 2020 Earnings Call Transcript
CVS Health Corp. (CVS) Q1 2020 earnings call dated May 06, 2020 Corporate Participants: Valerie C. Haertel -- Senior Vice President, Investor Relations Larry
Alexion Pharmaceuticals Inc (NASDAQ: ALXN) Q1 2020 Earnings Call Transcript
Alexion Pharmaceuticals Inc (ALXN) Q1 2020 earnings call dated May. 06, 2020 Corporate Participants: Chris Stevo -- Head of Investor Relations Ludwig Hantson -- Chief Executive
Infographic: CVS Health Corporation (CVS) Q1 2020 earnings results
CVS Health Corporation (NYSE: CVS) reported first quarter 2020 earnings results today. Total revenues increased 8.3% to $66.8 billion,driven mainly by strong
Alexion Pharmaceuticals (ALXN) Q1 profit drops 5% but beats estimates
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported its financial results for the quarter ended March 31, 2020, on Wednesday before the market opens.